180 related articles for article (PubMed ID: 19337695)
1. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection.
Akbar U; Jones T; Winestone J; Michael M; Shukla A; Sun Y; Duntsch C
J Neurooncol; 2009 Sep; 94(2):203-12. PubMed ID: 19337695
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
Heimberger AB; Archer GE; McLendon RE; Hulette C; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2000 Oct; 6(10):4148-53. PubMed ID: 11051269
[TBL] [Abstract][Full Text] [Related]
6. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
[TBL] [Abstract][Full Text] [Related]
7. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
[TBL] [Abstract][Full Text] [Related]
8. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
[TBL] [Abstract][Full Text] [Related]
9. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
10. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
11. A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients.
Rosso L; Brock CS; Gallo JM; Saleem A; Price PM; Turkheimer FE; Aboagye EO
Cancer Res; 2009 Jan; 69(1):120-7. PubMed ID: 19117994
[TBL] [Abstract][Full Text] [Related]
12. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
[TBL] [Abstract][Full Text] [Related]
13. The temozolomide derivative 2T-P400 inhibits glioma growth via administration route of intravenous injection.
Li R; Tang D; Zhang J; Wu J; Wang L; Dong J
J Neurooncol; 2014 Jan; 116(1):25-30. PubMed ID: 24065569
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
15. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model.
Zhang X; Guo M; Shen L; Hu S
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):603-12. PubMed ID: 25449156
[TBL] [Abstract][Full Text] [Related]
16. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
[TBL] [Abstract][Full Text] [Related]
17. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
18. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.
Brada M; Judson I; Beale P; Moore S; Reidenberg P; Statkevich P; Dugan M; Batra V; Cutler D
Br J Cancer; 1999 Nov; 81(6):1022-30. PubMed ID: 10576660
[TBL] [Abstract][Full Text] [Related]
19. [Glioma therapy up-date].
de la Fuente BP; Dalmau J; Rosenfeld M
Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
[TBL] [Abstract][Full Text] [Related]
20. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
Miki Y; Akimoto J; Omata H; Moritake K; Hiranuma M; Hironaka C; Fujiwara Y; Beppu M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):556-64. PubMed ID: 25262961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
